|
| N (n = 15) | M (n = 15) |
| Tumor size | ||
| T0 | 0 (0.0%) | 0 (0.0%) |
| T1 | 2 (13.3%) | 3 (20.0%) |
| T2 | 11 (73.3%) | 10 (66.7%) |
| T3 | 2 (13.3%) | 2 (13.3%) |
| Lymph node | ||
| N0 | 3 (20.0%) | 0 (0.0%) |
| N1 | 5 (33.3%) | 5 (33.3%) |
| N2 | 4 (26.7%) | 9 (60.0%) |
| N3 | 3 (20.0%) | 1 (6.7%) |
| ER, PR | ||
| −ve | 1 (6.7%) | 3 (20.0%) |
| +ve | 14 (93.3%) | 12 (80.0%) |
| HER2 | ||
| −ve | 9 (60.0%) | 6 (40.0%) |
| +ve | 6 (40.0%) | 9 (60.0%) |
| Tumor grade | ||
| 0 | 0 (0.0%) | 0 (0.0%) |
| 1 | 1 (6.7%) | 0 (0.0%) |
| 2 | 11 (73.3%) | 11 (73.3%) |
| 3 | 3 (20.0%) | 4 (26.7%) |